Change in Process of Care Measures
| Intervention | Control | |||||||
|---|---|---|---|---|---|---|---|---|
| Clinic 1 | Clinic 2 | Clinic 1 | Clinic 2 | |||||
| Pre- | Post- | Pre- | Post- | Pre- | Post- | Pre- | Post- | |
| Group 1*: Patients with type II diabetes who did not screen positive for depression or diabetes distress, N (%) | ||||||||
| Screening PHQ-2 or 9 | 30 (60%) | 15 (30%) | 12 (24%) | 21 (42%) | 32 (62%) | 29 (58%) | 29 (58%) | 36 (72%) |
| Screening diabetes distress (DD) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Up-to-date A1C screening | 41 (82%) | 38 (76%) | 44 (88%) | 47 (95%) | 37 (74%) | 30 (60%) | 46 (92%) | 47 (94%) |
| Up-to-date nephrology screening | 44 (88%) | 38 (76%) | 44 (88%) | 39 (77%) | 30 (60%) | 23 (46%) | 47 (94%) | 47 (94%) |
| Up-to-date cholesterol screening | 31 (62%) | 27 (54%) | 36 (72%) | 36 (72%) | 34 (68%) | 31 (62%) | 36 (72%) | 28 (58%) |
| Group 2**: Patients with type II diabetes who screened positive for depression or diabetes distress, N (%) | ||||||||
| Screening PHQ-2 or 9 | 2 (7%) | 3 (10%) | 0 (0%) | 0 (0%) | 12 (40%) | 10 (33%) | 8 (27%) | 13 (43%) |
| Screening diabetes distress (DD) | 0 (0%) | 11 (37%) | 0 (0%) | 1 (25%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Up-to-date A1C screening | 26 (87%) | 26 (87%) | 4 (100%) | 4 (100%) | 25 (83%) | 25 (83%) | 28 (93%) | 25 (83%) |
| Up-to-date nephrology screening | 25 (83%) | 29 (97%) | 4 (100%) | 3 (75%) | 15 (50%) | 23 (78%) | 24 (80%) | 26 (87%) |
| Up-to-date cholesterol screening | 18 (60%) | 20 (67%) | 2 (50%) | 3 (75%) | 19 (63%) | 27 (90%) | 21 (70%) | 21 (70%) |